Physician profile
John K Lam
NPI 1174759955
$9,350.84
in general payments reported to CMS, 2019-2025
9 companies · $1,216 in 2025
The $1,216 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $132 · 2022: $991 · 2023: $1,406 · 2024: $5,067 · 2025: $1,216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,807 · Education: $2,650 · Food and Beverage: $2,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,807.36 |
| Education | $2,649.76 |
| Food and Beverage | $2,232.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,327.03 | 2024 | |
| Zimmer Biomet Holdings, INC. | $3,106.51 | 2022-2025 | Advantagerib, Ribfix Titan, Ribfix Blu Advantage |
| Aroa Biosurgery Incorporated | $380.47 | 2019-2024 | |
| Kerecis Limited | $340.93 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Access Pro Medical, LLC | $294.37 | 2025 | Matriderm |
| Kci USA, INC. | $285.66 | 2019-2022 | |
| Polynovo North America LLC | $267.88 | 2020-2025 | Novosorb Btm |
| Smith+Nephew, INC. | $227.66 | 2019-2024 | Stravix |
| Portola Pharmaceuticals, LLC | $120.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.